nonprofit logo

International Association For The Study Of Lung Cancer

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 200499338 ✦ Denver, CO ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is International Association For The Study Of Lung Cancer?

The International Association for the Study of Lung Cancer (IASLC) is a prominent nonprofit organization situated in Denver, Colorado. Its primary mission is to advance the comprehension of lung cancer and other thoracic malignancies. This includes investigating their origins, prevalence, prevention, diagnosis, treatment, and various other aspects. The association strives to disseminate knowledge about these conditions to its members, the medical community, and the general public. In pursuit of its mission, IASLC employs all available resources to eliminate lung cancer and other thoracic malignancies as a significant health concern for individual patients and globally. With a workforce of 35 dedicated individuals, IASLC offers membership and various programs that contribute to this noble objective.


Official website here: www.iaslc.org

What are the reviews and ratings of this charity?

The International Association for the Study of Lung Cancer (IASLC) has earned a score of 91%, resulting in a Four-Star out of Four Star rating from Charity Navigator. This high rating reflects the organization's strong accountability and financial management, as well as its robust practices in culture and community engagement. The IASLC's mission and strategic goals focus on advancing scientific knowledge, promoting global education, and advocating for accessible multidisciplinary care in lung and thoracic cancer treatment.

The organization's Accountability & Finance beacon highlights a strong performance with 88 points, showcasing effective financial oversight, a fully independent board, and no material diversion of assets. However, there are areas for improvement, such as missing a whistleblower policy and the absence of certain documents on their website. Despite these gaps, IASLC maintains a robust financial structure with a favorable liabilities to assets ratio and a high program expense ratio, underscoring its focus on funding core mission activities.

IASLC excels in the Culture & Community and Leadership & Adaptability categories, scoring 100 in both. This indicates that the organization effectively gathers, utilizes, and acts on constituent feedback, while also investing in leadership development. Their adaptability is evidenced by the creation of a new 5-year strategic plan to support stakeholders post-Covid, positioning IASLC as a leader in fostering innovation and collaboration within the field of lung cancer research.


This AI summary has been generated from information found on Charity Navigator.

Is International Association For The Study Of Lung Cancer legitimate?

International Association For The Study Of Lung Cancer is a legitimate nonprofit organization registered as a 501(c)(3) entity. International Association For The Study Of Lung Cancer submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $539,836
Professional Fundraising Fees: $0
Other Salaries and Wages: $2,957,452

For more financial information, click here


Official website here: www.iaslc.org

What is the mission statement of International Association For The Study Of Lung Cancer?

The International Association for the Study of Lung Cancer (IASLC) is committed to advancing the understanding of lung cancer and other thoracic malignancies. Their mission involves conducting research into the causes, prevention, diagnosis, and treatment of these diseases. They aim to disseminate this knowledge to their members, the medical community, and the general public to raise awareness and promote education about these health threats. IASLC utilizes all available means to eliminate lung cancer and other thoracic malignancies as a significant health concern for individual patients and globally.


Official website here: www.iaslc.org

Who is the CEO of International Association For The Study Of Lung Cancer?

John Skadow is the President of International Association For The Study Of Lung Cancer. The CEO's salary of International Association For The Study Of Lung Cancer is $193,216 and their total compensation is $211,705.


Official website here: www.iaslc.org

What is the revenue of International Association For The Study Of Lung Cancer?

International Association For The Study Of Lung Cancer's revenue in 2022 was $11,551,380.


Official website here: www.iaslc.org

Who are the executives of International Association For The Study Of Lung Cancer and what are their salaries?

The average compensation at International Association For The Study Of Lung Cancer during 2022 was $99,923. There are 35 employees at International Association For The Study Of Lung Cancer.


Here are 22 key members and their salaries (International Association For The Study Of Lung Cancer's CEO's salary is $193,216 and their total compensation is $211,705):


Heather Wakelee Md (President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Erik Thunnissen Md (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Tetsuya Mitsudomi Md Phd (Past President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Paul Van Schil Md (President Elect)
  • Compensation: $0
  • Related: $0
  • Other: $0
Young Tae Kim Md Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Joachim Aerts Md Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Roy Herbst Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Andrea Bezjak Md (Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0
Morten Quist Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Carlos Gil Ferreira Md Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jhanelle Gray Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Caicun Zhou Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Lecia Vandam Sequist Md Mph (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Ming-Sound Tsao Md Frcpc (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Paula Ugalde Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Karen L Kelly (Ceo)
  • Compensation: $332,435
  • Related: $0
  • Other: $37,118
John Skadow (Cfo)
  • Compensation: $207,401
  • Related: $0
  • Other: $46,233
Murry Wynes (Director Of Scientific Aff)
  • Compensation: $200,847
  • Related: $0
  • Other: $31,122
Matthew C Yeingst (Chief Development Officer)
  • Compensation: $184,040
  • Related: $0
  • Other: $44,559
Rebecca Bunn (Senior Advisor Scientific)
  • Compensation: $136,348
  • Related: $0
  • Other: $29,170
Kathleen M Doherty (Director, Hr)
  • Compensation: $133,846
  • Related: $0
  • Other: $24,157
Kristin Richeimer (Former Interim Ceo)
  • Compensation: $193,216
  • Related: $0
  • Other: $18,489


Official website here: www.iaslc.org

Where can I find the form 990 for International Association For The Study Of Lung Cancer?

International Association For The Study Of Lung Cancer's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.iaslc.org

Learn more at the official website: www.iaslc.org

Mission Statement of International Association For The Study Of Lung Cancer

The International Association for the Study of Lung Cancer (IASLC) is dedicated to advancing the understanding of lung cancer and other thoracic malignancies on a global scale. Their mission encompasses promoting research into the causes, prevalence, prevention, diagnosis, treatment, and various aspects of these diseases. IASLC strives to educate and inform its members, the medical community at large, and the public about these conditions. Furthermore, the association utilizes all available resources to eliminate lung cancer and other thoracic malignancies as a health threat for individual patients and worldwide. The ultimate goal of IASLC is to eradicate these diseases and improve the overall health of affected individuals.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The International Association for the Study of Lung Cancer (IASLC) plays a pivotal role in advancing the understanding and management of lung cancer and other thoracic malignancies. By promoting comprehensive research into the etiology, epidemiology, prevention, diagnosis, and treatment of these diseases, the IASLC contributes significantly to the medical and scientific community's knowledge base.

Through its various programs and memberships, IASLC disseminates crucial information and educational resources not only to its members but also to the broader medical community and the public. This commitment to education fosters awareness and understanding, which are essential for improving outcomes for patients affected by lung cancer.

Furthermore, the organization's mission to eliminate lung cancer as a health threat underscores its dedication to global health improvement. By utilizing all available means, the IASLC strives to reduce the incidence and mortality associated with lung cancer, ultimately advancing public health and enhancing patient care. Its impact is felt worldwide, as it addresses these pressing health challenges on a global scale.




This information is meant to be a general summary of International Association For The Study Of Lung Cancer. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$11,551,380 (2022)
Expenses
$14,627,829 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: -$5,842,161
  • Program Service Revenue: $16,694,390
  • Gross Receipts: $17,603,769

Assets and Liabilities:

  • Total Assets: $25,381,895
  • Total Liabilities: $10,197,977
  • Net Assets: $15,183,918

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

MEETING INCOME

Revenue

$13,462,619

PUBLICATIONS

Revenue

$1,761,108

SCIENTIFIC PROJECTS

Revenue

$1,452,703

WEB SEMINARS

Revenue

$17,960

Organization Details

Founding Year

2003

Principal Officer

John Skadow

Main Address

999 17TH ST STE 200, DENVER, CO, 802022725

NTEE Category

Code: S41 - Community improvement

If you are a representative of International Association For The Study Of Lung Cancer and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.